Literature DB >> 23611589

Brain tumor epidemiology in Austria and the Austrian Brain Tumor Registry.

Adelheid Woehrer1.   

Abstract

Cancer registries provide incidence and mortality data on patients with cancer at the population level. Cancer registration is most often restricted to the group of malignant neoplasms, whereas information on benign and intermediate tumors is generally not available. Brain tumors however differ from other sites by 1) the large spectrum of different tumor types, and 2) the exclusive localization in proximity to eloquent areas with considerable neurological comorbidity and mortality irrespective of their biological behavior. In order to obtain a comprehensive overview of the brain tumor burden, specialized brain tumor registries, which provide information on all brain tumor types, have emerged in several countries. This thesis synopsis summarizes the Austrian experience on the establishment of such a specialized brain tumor registry: the Austrian Brain Tumor Registry (ABTR). The initial steps are reported - from consensus and commitment of the Austrian Society of Neuropathology, formation of an interdisciplinary team of experts, setup of the infrastructure including data confidentiality issues, to the sustained support of the Austrian neurooncology community and major cooperation with the Austrian National Cancer Registry. ABTR differs from other registries by its scientific setting and neuropathological background warranting strong expertise in brain tumor typing and tissue-based research. Thereby, ABTR constitutes also a virtual brain tumor biobank. By having achieved these steps, first investigational results demonstrate that ABTR provides valid and accurate population-based incidence and survival data for individual brain tumor types. The exact incidence of rare tumor entities is estimated, key diagnostic criteria of newly proposed tumor entities are refined, common standards for testing of molecular markers are advocated, and medical progress via real-life outcome analyses is assessed. The diverse scientific contributions highlight the enormous scientific potential of ABTR for continued work.

Entities:  

Mesh:

Year:  2013        PMID: 23611589     DOI: 10.5414/NP300600

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  8 in total

1.  Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).

Authors:  Anna Sophie Berghoff; Gerda Ricken; Dorothee Wilhelm; Orsolya Rajky; Georg Widhalm; Karin Dieckmann; Peter Birner; Rupert Bartsch; Matthias Preusser
Journal:  J Neurooncol       Date:  2016-07-19       Impact factor: 4.130

2.  αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer.

Authors:  Anna Sophie Berghoff; Astrid Kerstin Kovanda; Thomas Melchardt; Rupert Bartsch; Johannes A Hainfellner; Bence Sipos; Jens Schittenhelm; Christoph C Zielinski; Georg Widhalm; Karin Dieckmann; Michael Weller; Simon L Goodman; Peter Birner; Matthias Preusser
Journal:  Clin Exp Metastasis       Date:  2014-08-24       Impact factor: 5.150

3.  Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

Authors:  Alba A Brandes; Enrico Franceschi; Mario Ermani; Alicia Tosoni; Fiorenzo Albani; Roberta Depenni; Marina Faedi; Anna Pisanello; Girolamo Crisi; Benedetta Urbini; Claudio Dazzi; Luigi Cavanna; Claudia Mucciarini; Giuseppe Pasini; Stefania Bartolini; Gianluca Marucci; Luca Morandi; Elena Zunarelli; Serenella Cerasoli; Giorgio Gardini; Giovanni Lanza; Enrico Maria Silini; Silvio Cavuto; Agostino Baruzzi; A Baruzzi; F Albani; F Calbucci; R D'Alessandro; R Michelucci; A Brandes; V Eusebi; S Ceruti; E Fainardi; R Tamarozzi; E Emiliani; M Cavallo; E Franceschi; A Tosoni; M Cavallo; F Fiorica; A Valentini; R Depenni; C Mucciarini; G Crisi; E Sasso; C Biasini; L Cavanna; D Guidetti; N Marcello; A Pisanello; A M Cremonini; G Guiducci; S de Pasqua; S Testoni; R Agati; G Ambrosetto; A Bacci; E Baldin; A Baldrati; E Barbieri; S Bartolini; E Bellavista; F Bisulli; E Bonora; F Bunkheila; V Carelli; M Crisci; P Dall'Occa; D de Biase; S Ferro; C Franceschi; G Frezza; V Grasso; M Leonardi; G Marucci; V Mazzocchi; L Morandi; B Mostacci; G Palandri; E Pasini; M Pastore Trossello; A Pession; M Ragazzi; P Riguzzi; R Rinaldi; S Rizzi; G Romeo; F Spagnolli; P Tinuper; C Trocino; S Cerasoli; M Dall'Agata; M Faedi; M Frattarelli; G Gentili; A Giovannini; P Iorio; U Pasquini; G Galletti; C Guidi; W Neri; A Patuelli; S Strumia; M Casmiro; A Gamboni; F Rasi; G Cruciani; P Cenni; C Dazzi; Ar Guidi; F Zumaglini; A Amadori; G Pasini; M Pasquinelli; E Pasquini; A Polselli; A Ravasio; B Viti; M Sintini; A Ariatti; F Bertolini; G Bigliardi; P Carpeggiani; F Cavalleri; S Meletti; P Nichelli; E Pettorelli; G Pinna; E Zunarelli; F Artioli; I Bernardini; M Costa; G Greco; R Guerzoni; C Stucchi; C Iaccarino; R Rizzi; G Zuccoli; P Api; F Cartei; E Fallica; E Granieri; F Latini; G Lelli; C Monetti; V Ramponi; A Saletti; R Schivalocchi; S Seraceni; M R Tola; B Urbini; C Giorgi; E Montanari; D Cerasti; P Crafa; I Dascola; I Florindo; S Mazza; F Servadei; Em Silini; P Torelli; P Immovilli; N Morelli; C Vanzo
Journal:  Neurooncol Pract       Date:  2014-08-28

4.  Density of tumor-infiltrating lymphocytes correlates with extent of brain edema and overall survival time in patients with brain metastases.

Authors:  Anna S Berghoff; Elisabeth Fuchs; Gerda Ricken; Bernhard Mlecnik; Gabriela Bindea; Thomas Spanberger; Monika Hackl; Georg Widhalm; Karin Dieckmann; Daniela Prayer; Amelie Bilocq; Harald Heinzl; Christoph Zielinski; Rupert Bartsch; Peter Birner; Jerome Galon; Matthias Preusser
Journal:  Oncoimmunology       Date:  2015-06-09       Impact factor: 8.110

5.  Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.

Authors:  Anna Sophie Berghoff; Barbara Kiesel; Georg Widhalm; Orsolya Rajky; Gerda Ricken; Adelheid Wöhrer; Karin Dieckmann; Martin Filipits; Anita Brandstetter; Michael Weller; Sebastian Kurscheid; Monika E Hegi; Christoph C Zielinski; Christine Marosi; Johannes A Hainfellner; Matthias Preusser; Wolfgang Wick
Journal:  Neuro Oncol       Date:  2014-10-29       Impact factor: 12.300

6.  Relative survival of patients with non-malignant central nervous system tumours: a descriptive study by the Austrian Brain Tumour Registry.

Authors:  A Woehrer; M Hackl; T Waldhör; S Weis; J Pichler; A Olschowski; J Buchroithner; H Maier; G Stockhammer; C Thomé; J Haybaeck; F Payer; G von Campe; A Kiefer; F Würtz; G H Vince; R Sedivy; S Oberndorfer; F Marhold; K Bordihn; W Stiglbauer; U Gruber-Mösenbacher; R Bauer; J Feichtinger; A Reiner-Concin; W Grisold; C Marosi; M Preusser; K Dieckmann; I Slavc; B Gatterbauer; G Widhalm; C Haberler; J A Hainfellner
Journal:  Br J Cancer       Date:  2013-11-19       Impact factor: 7.640

7.  A Nationwide, Population-Based Epidemiology Study of Primary Central Nervous System Tumors in Korea, 2007-2016: A Comparison with United States Data.

Authors:  Ho Kang; Sang Woo Song; Johyun Ha; Young-Joo Won; Chul-Kee Park; Heon Yoo; Kyu-Won Jung
Journal:  Cancer Res Treat       Date:  2020-10-07       Impact factor: 4.679

8.  DNA Methylation Associates With Clinical Courses of Atypical Meningiomas: A Matched Case-Control Study.

Authors:  Matthias Millesi; Alice Senta Ryba; Johannes A Hainfellner; Thomas Roetzer; Anna Sophie Berghoff; Matthias Preusser; Gerwin Heller; Erwin Tomasich; Felix Sahm; Karl Roessler; Stefan Wolfsberger
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.